BIRD Newsletter - February 2011


Executive Director's Perspective

Year 2010 is just behind us. It was a year in which we saw a slow recovery of the world economy, and realized that the ripples of the great economic crisis are still going to accompany us for a while. For many established firms and young companies, 2010 was still a time of struggle and recovery.For 33 years BIRD has been active in promoting and supporting U.S.-Israel collaboration in industrial R&D. Each year brings its own developments and surprises, adding to the continuous accumulation of experiences and know-how. At the climax of the crisis, about two years ago, we were wondering how the rough economic situation will affect start-ups and young companies and how large companies will react in the area of external innovation search. We thought then that for both Israeli and American companies it was strategically important to continue seeking partnerships. Supporting both Israeli and U.S. companies by introducing them to one another and facilitating their partnerships - “matchmaking” - is the core of BIRD’s activities.

Click here to view the full article

Eitan Yudilevich, Ph.D.
Executive Director

BIRD Submission Dates

The following are the upcoming deadlines for submission:

Monday, March 14, 2011 – Executive Summary of the Proposal
Thursday, April 14, 2011 –
Final Proposal
Board of Governors: June 2011

BIRD Energy Submission Dates

"BIRD Energy” is a program for U.S.- Israeljoint renewable energy developments funded by the U.S. Department of Energy (DOE), the Israel Ministry of National Infrastructures and the BIRD Foundation.
"BIRD Energy” follows the same rules and procedures as BIRD.


The following are the upcoming deadlines for BIRD Energy:


Thursday, May 05, 2011 Executive Summary of the Proposal
Thursday, June 30, 2011 – 
Final Proposal
Decisions: September 2011

Click here for the Call for Proposals


Latest Investments

BIRD Invested $5.4 million in six projects - December 14, 2010

The approved projects involve innovations in the areas of communications, healthcare, IT and personalized medicine.
In addition to the grants from BIRD, the projects will access private sector funding, boosting the total value of all projects to $15.4 million.

To view the list of approved projects please click here 


Spotlight on BIRD Projects



McGraw-Hill Education Acquires Tegrity while teaming to develop advanced learning system with the support of BIRD Foundation.

McGraw-Hill Education, a division of the McGraw-Hill Companies, Inc. (NYSE:MHP), announced on October 2010 the acquisition of Tegrity, a Provider of Award-winning, Automated Service that Captures Class Lectures for College Students. In 2009, the companies received a BIRD grant to develop LOTUS- an advanced learning system.
Tegrity’s lecture capture has been a core feature of McGraw-Hill Connect since the platform’s debut in fall 2009.
In the course of the BIRD supported project, while developing the Lotus system, the companies reached an agreement according to which McGraw-Hill Education announced the acquisition of Tegrity.
Tegrity’s expertise and innovative lecture capture technology bolsters McGraw-Hill’s ability to develop and deliver the next generation of digital learning services.

Click here to view the whole article

Isaac Segal,
President, Tegrity



On December 2007, the BIRD Board of Governors approved the project between the Israeli company BioCancell and the Virginia Business Development Center (VBDC) to carry out PHASE I SAFETY AND DOSING TRIAL FOR PANCREATIC CANCER THERAPY. The following is a recent report by BioCancell on the project success.

BioCancell Announces Success in Phase I/IIa Pancreatic Cancer Clinical Trial

In October 2010, BioCancell Therapeutics announced success in meeting the goals of its Phase I/IIa clinical trial of product-candidate BC-819 as a treatment for pancreatic cancer, namely the safety and preliminary efficacy of the product. The clinical trial took place in Israel and in the US in the University of Maryland Medical Center (NCI-designated), and was partially funded by a BIRD grant in the amount of $950,000. Based on the results of the clinical trial, and the results of a successful pre-clinical study, that examined the sequential administration of BC-819 with FDA-approved drug Gemzar (Gemcitabine), as treatment for pancreatic cancer, BioCancell intends to prepare to apply to the Food and Drug Administration (FDA) to receive approval for an international Phase IIb clinical trial.

Click here to read the whole report


Upcoming Events



February 10, 2011 – IBM, Petach Tikva
Under the auspices of the Israel Association for Medical Informatics and the Society of Electrical and Electronic Engineers in Israel, a special interest group - Technologies for Aging Well, will hold a workshop titled: “New Challenge: Gerotechnology – The Development of Technologies Aimed for Quality Aging”. Among the participants are Industry, Academy and Societal Services professionals and the moderator is Dr. Bat Ami Sadan from Vaica Ltd. 

February 22-24, 2011 - The Eilat-Eilot Renewable Energy Conference and Exhibition
The conference brings together thousands of participants from abroad and Israel and is among the world’s leading platforms for presenting technological innovation, business opportunities, policies and implementation in the renewable energy field.  Dr. Eitan Yudilevich will moderate the Plenary Session “Do We See the Light?” on February 22. In addition, BIRD is also coordinating panel discussions in Alternative Fuels and Mobile Power on Wednesday, February 23, and will be setting up one-on-one-meetings during the conference.
Click here for further information 

March 1, 2011 – Alternative & Funding Innovative Projects: BIRD Foundation
The seminar presenting the BIRD Foundation’s model of funding joint development projects between Israeli and American companies will take place in Ben Gurion University and is supported by The Ben-Gurion University of the Negev, Israel’s Manufacturers Association and the Municipality of Beer Sheba.
Companies interested in partnerships and entrepreneurs will find this program to be of great value
Click here for further information 

March 9-10, 2011 - Financial IT Delegation, California
A delegation of Israeli high-tech companies focusing on the Financial IT industry, will visit the Bay Area with the objective of meeting and establishing initial business relationships with local companies. 
Click here for further information

PrintTell a friend
Jump to page content